Protective effects of SM-20302, an orally active GPIIb/IIIa antagonist, in an ADP/epinephrine-induced guinea pig model of transient cerebral ischemia

Thrombosis Research

Volumn 101, Issue 3, 2001, Pages 119-126

  Horisawa, S ^a   Kaneko, M ^a   Sakurama, T ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Carotid artery thrombosis; GPIIb IIIa receptor antagonist; Platelet aggregation; SM 20302

Indexed keywords

3 (3 (4 AMIDINOBENZOYLAMINO)PROPANOYLAMINO) 2 (4 ETHYL)BENZENSULFONYLAMINOPROPIONIC ACID HYDROCHLORIDE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; FIBRINOGEN RECEPTOR ANTAGONIST; SM 23302; TICLOPIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; GUINEA PIG; HEMISPHERE; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TRANSIENT ISCHEMIC ATTACK;

ADMINISTRATION, ORAL; ANIMALS; BENZENE DERIVATIVES; EPINEPHRINE; GUINEA PIGS; ISCHEMIC ATTACK, TRANSIENT; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 0035251810     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00378-9     Document Type: Article

References (29)

1. Special report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases III
2. Secondary prevention of vascular disease by prolonged anti-platelet therapy
3. Collaborative overview of randomised trials of antiplatelet treatment: Part I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
4. Antiplatelet therapy in the prevention of ischemic stroke
5. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients
6. Platelet membrane glycoprotein IIb/IIIa: Member of a family of Arg-Gly-Asp specific adhesion receptors
7. The platelet membrane glycoprotein IIb-IIIa complex
8. New antiplatelet agents: Platelet GPIIb/IIIa antagonists
9. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
10. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty
11. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
12. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
13. SM-20302, a novel GPIIb/IIIa antagonist, has shown a selective antithrombotic activity without increasing the risk of hemorrhage in vivo
14. SM-20302, a nonpeptide GPIIb/IIIa receptor antagonist, exhibits a wide therapeutic window in a newly developed hemorrhage model in mice
15. In vivo efficacy of SM-20302, a GPIIb/IIIa receptor antagonist, correlates with the ex vivo platelet inhibition in heparinized blood but not in citrated blood
16. Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs
17. Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically-induced thrombosis model in guinea pigs
18. Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model
19. Animal model of TIA: An experimental study with intracarotid ADP infusion in rabbits
20. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination
21. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: Comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban
22. The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIb/IIIa antagonist
23. Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues
24. Arachidonate-induced cerebrovascular occlusion in the rat
25. Platelet emboli and focal cerebral ischemia: An experimental study on the circulatory and metabolic effects of intracarotid infusion of ADP and arachidonic acid in rabbits
26. Induction of reproducible brain infarction by photochemically initiated thrombosis
27. Cerebral ischemia: II. The no-reflow phenomenon
28. Impaired microvascular filling after focal cerebral ischemia in monkeys
29. Transient appearance of 'no reflow' phenomenon in Mongolian gerbils